We are pleased to announce the publication of our latest SureChEMBL paper, " SureChEMBL in 2026: an open database of chemical and biomedical annotations from the patent literature ", in Nucleic Acids Research . The paper presents a major redesign of SureChEMBL , including modernised infrastructure, improved chemical extraction and standardisation workflows, and new biomedical annotations that connect patent chemistry to genes, proteins, diseases and mechanisms. The updated resource provides open access to 122 million patents, 44 million chemically annotated documents, 31 million chemical structures and 1 million biomedical entity annotations. Abstract The patent literature is a major source of scientific and technical information for drug discovery, often disclosing chemical structures, biological targets, therapeutic indications, and structure-activity relationships before they appear in the scientific literature. However, patent documents are difficult to analyse at scale b...
We are excited to announce that the new SureChEMBL's beta version is now out and can be accessed at: https://www.surechembl.org/beta/ We’d love for you to try our new web interface and share your feedback. As we gradually move to the new web interface and APIs, we’re aiming to complete the transition by the end of 2026. If you use our APIs, we encourage you to start exploring the new versions too. Please let us know if you have any questions or need help getting started. What’s Changing The new web interface, currently in beta, is live at https://www.surechembl.org/beta/ and will replace the current interface. Please migrate to our new REST APIs as old APIs would be discontinued after the release. SureChEMBL downloads continue to be available via FTP at https://ftp.ebi.ac.uk/pub/databases/chembl/SureChEMBL/bulk_data/ Web Interface SureChEMBL’s web interface has been redesigned using Nuxt 3 to improve the user experience and support asynchronous annotation using LeadMine. It’s c...